HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

RoC review

This article was originally published in The Rose Sheet

Executive Summary

National Toxicology Program will accept comments on the "current process for reviewing nominations for listing in or delisting from the Report on Carcinogens and on the current listing criteria used for evaluating the nominations" at Jan. 27-28 meeting at the National Institutes of Health in Bethesda, Md., NTP announces in Dec. 3 Federal Register notice. Oral comments may be made during the meeting, while written comments submitted by Jan. 15 will be distributed to the panel and posted on the NTP RoC Web site prior to the meeting. An additional meeting will be held Jan. 29 to discuss the "NTP Vision for the 21st Century," a plan "to move toxicology from a predominately observational science at the level of disease-specific models to a predominately predictive science focused upon a broad inclusion of target-specific, mechanism-based, biological observations"...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS011736

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel